共 85 条
[1]
Wagner AD(2010)Chemotherapy for advanced gastric cancer Cochrane Database Syst Rev 3 CD004064-392
[2]
Unverzagt S(2010)Advanced gastric cancer—slow but steady progress Cancer Treat Rev 36 384-221
[3]
Grothe W(2008)S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 3 215-46
[4]
Power DG(2008)Upper gastrointestinal clinical studies group of the National Cancer Research Institute of the United Kingdom. Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 36-2004
[5]
Kelsen DP(2002)Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer J Clin Oncol 20 1996-267
[6]
Shah MA(1997)Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer J Clin Oncol 15 261-891
[7]
Koizumi W(2010)A randomised phase 2 study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer Eur J Cancer 46 885-315
[8]
Narahara H(2003)Gastric cancer Lancet 362 305-4997
[9]
Hara T(2001)A prospective randomised Phase 3 trial of 5-fluorouracil and cisplatin versus epirubicin, cisplatin and 5FU in the treatment of patients with previously untreated advanced gastric cancer Eur J Cancer 37 1160a-21
[10]
Cunningham D(2006)V325 study group. Phase 3 study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group J Clin Oncol 24 4991-1887